Literature DB >> 24295050

Ca2+/S100 proteins inhibit the interaction of FKBP38 with Bcl-2 and Hsp90.

Seiko Shimamoto, Mitsumasa Tsuchiya1, Fuminori Yamaguchi2, Yasuo Kubota3, Hiroshi Tokumitsu1, Ryoji Kobayashi1.   

Abstract

FKBP38 (FK506-binding protein 38), a membrane-anchored TPR (tetratricopeptide repeat)-containing immunophilin, regulates signalling pathways such as cell survival, apoptosis, proliferation and metastasis. However, the mechanisms that regulate the activity of FKBP38 are, at present, poorly understood. We previously reported that Ca2+/S100 proteins directly associate with the TPR proteins, such as Hop [Hsp70 (heat-shock protein of 70 kDa)/Hsp90-organizing protein], kinesin-light chain, Tom70 (translocase of outer mitochondrial membrane 70), FKBP52, CyP40 (cyclophilin 40), CHIP (C-terminus of Hsc70-interacting protein) and PP5 (protein phosphatase 5), leading to the dissociation of the interactions of the TPR proteins with their target proteins. Therefore we have hypothesized that Ca2+/S100 proteins can interact with FKBP38 and regulate its function. In vitro binding studies demonstrated that S100A1, S100A2, S100A6, S100B and S100P specifically interact with FKBP38 and inhibit the interaction of FKBP38 with Bcl-2 and Hsp90. Overexpression of permanently active S100P in Huh-7 cells inhibited the interaction of FKBP38 with Bcl-2, resulting in the suppression of Bcl-2 stability. The association of the S100 proteins with FKBP38 provides a Ca2+-dependent regulatory mechanism of the FKBP38-mediated signalling pathways.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24295050     DOI: 10.1042/BJ20130924

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

1.  Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors.

Authors:  Lei Zhang; Maria B Hapon; Alicia A Goyeneche; Rekha Srinivasan; Carlos D Gamarra-Luques; Eduardo A Callegari; Donis D Drappeau; Erin J Terpstra; Bo Pan; Jennifer R Knapp; Jeremy Chien; Xuejun Wang; Kathleen M Eyster; Carlos M Telleria
Journal:  Mol Oncol       Date:  2016-05-17       Impact factor: 6.603

Review 2.  S100A2 protein and non-small cell lung cancer. The dual role concept.

Authors:  Panagiotis Hountis; Dimitrios Matthaios; Marios Froudarakis; Demosthenes Bouros; Stylianos Kakolyris
Journal:  Tumour Biol       Date:  2014-05-27

3.  Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Qingdu Decoction against Chronic Liver Injury.

Authors:  Chongyang Ma; Mengpei Zhao; Yuqiong Du; Shuang Jin; Xiaoyi Wu; Haiyan Zou; Qiuyun Zhang; Lianyin Gao
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-03       Impact factor: 2.629

4.  Effects of miR-21 on proliferation and apoptosis in human gastric adenocarcinoma cells.

Authors:  Jun-Bao Gu; Xue-Bin Bao; Zhao Ma
Journal:  Oncol Lett       Date:  2017-05-15       Impact factor: 2.967

5.  Down-regulation of S100P induces apoptosis in endometrial epithelial cell during GnRH antagonist protocol.

Authors:  Dan Zhang; Mi Han; Mingjuan Zhou; Mengyu Liu; Yan Li; Bufang Xu; Aijun Zhang
Journal:  Reprod Biol Endocrinol       Date:  2021-07-02       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.